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Abstract Damaged DNA-binding activity comprises two major
protein components, DDB1 and DDB2, which are implicated in
the repair of ultraviolet (UV) radiation-induced DNA damage.
The possible role of DDB2 as a determinant of cellular sensitivity
to UV was investigated. The abundance of DDB2 in UV-
resistant HeLa cell lines was increased compared with that in the
parental UV-sensitive cells. Stable transfection of the resistant
cells with DDB2 antisense cDNA resulted in marked depletion of
DDB2 protein and restored cellular sensitivity to UV-induced
apoptosis. Whereas the extent of UV-induced activation of
apoptosis executioners, including DNA fragmentation factor,
and caspase-3 were reduced in the UV-resistant cells compared
with those apparent in the sensitive cells, depletion of DDB2 from
the resistant cells restored the normal activation patterns for
these proteins. In contrast, overexpressing DDB2 in DDB2-
depleted cells with recombinant adenovirus, which carries ddb2
cDNA, markedly inhibited the extent of UV-induced activation
of DNA fragmentation factor, and caspase-3. Interestingly, a
mutated form of DDB2, which is defective in interacting with
DDB1 and binding to UV-damaged DNA, also markedly
inhibited the activation of apoptosis executioners. These results
indicate that DDB2 is a modulator of UV-induced apoptosis, and
that UV resistance can be overcome by inhibition of DDB2. The
findings also suggest that modulation of UV-induced apoptosis
by DDB2 may be independent of DNA repair. ß 2002 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
Ultraviolet (UV) radiation induces apoptosis by activation
of the Fas signaling pathway in a variety of cell types [1].
Multimerization of Fas at the cell surface induces the recruit-
ment of the signaling molecules FADD and caspase-8 to the
activated receptor, resulting in the formation of the death-
inducing signaling complex (DISC) [2,3]. Oligomerization of
caspase-8 within the DISC results in its autoactivation by
proteolysis [4] ; the activated protease then mediates the acti-
vation of other caspases, including caspase-3 [5,6], by proteo-
lytic cleavage. These downstream caspases cleave the death
substrates, including DNA fragmentation factor (DFF) [7,8],
that are central to apoptotic events such as changes in cell
morphology and DNA fragmentation [9].
Nucleotide excision repair is a versatile mechanism for the
repair of damaged DNA that operates in organisms ranging
from mycoplasma to mammals. The ability of a cell to recog-
nize damaged DNA is crucial in nucleotide excision repair and
is a key determinant of cell sensitivity to genotoxic agents,
including UV radiation. Damaged DNA-binding (DDB) ac-
tivity has been puri¢ed to apparent homogeneity from human
placenta and HeLa cells and characterized [10^12], and is
identical to a similar activity originally identi¢ed in human
placenta [13]. In vitro reconstitution studies have indicated
that DDB proteins stimulate nucleotide excision repair but
that they are not essential for this process [14]. Cells derived
from individuals with the inherited disorder xeroderma pig-
mentosum (XP) of complementation groups A^G exhibit a
reduced capacity for nucleotide excision repair of damaged
DNA [15], and DDB proteins have been implicated in the
primary defect of XP-E. Thus, whereas DDB activity, as mea-
sured by electrophoretic mobility shift assay, is increased in
UV-resistant cells [16^19], it is absent from or reduced in
several XP-E cell lines [20^23]. Furthermore, microinjection
of puri¢ed DDB proteins into XP-E cells corrected the defect
in DNA repair [24,25]. However, only indirect evidence sug-
gests that DDB activity contributes to DNA repair
[16,17,19,21].
DDB activity was originally puri¢ed as a single V127-kDa
protein from monkey cells [26] and as a complex of V127-
kDa (DDB1) and V48-kDa (DDB2) subunits from human
cells [11,27]. The gene encoding DDB1 has been isolated from
monkey [28] and human [29,30], and the protein has been
proposed to function in the recognition of DNA damage dur-
ing UV-induced nucleotide excision repair [31]. However, sev-
eral studies have shown that DDB1 is not essential for this
step [32]. The detection of mutations in the DDB2 gene in a
subset of XP-E cells that exhibit reduced or a lack of DDB
activity [27] suggested that DDB2 might contribute to nucle-
otide excision repair and to cell sensitivity to genotoxic stress.
The human DDB2 cDNA has been cloned [29] and the DDB2
protein was recently shown to require DDB1 in order to rec-
ognize DNA damaged by UV radiation [33]. However, the
role of DDB2 in determination of cellular sensitivity to UV
irradiation is unknown. We have now shown that antisense
cDNA-induced down-regulation of DDB2 expression over-
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comes the acquired resistance of cultured cells to UV radia-
tion.
2. Materials and methods
2.1. Cells and reagents
Antibodies to L-actin, to DFF, and to caspase-3 were obtained
from Santa Cruz Biotechnology. 4P,6-Diamidino-2-phenylindole
(DAPI) and other reagents were from Sigma, unless indicated other-
wise. Human cervical carcinoma HeLa cells were originally obtained
from American Type Culture Collection. UV-resistant HeLa-CPR
variants were maintained as previously described [34].
2.2. Cloning of DDB2 cDNA
An 1820-bp fragment of human DDB2 cDNA containing the entire
reading frame was isolated from a placental cDNA library (Quick-
Clone cDNA; Clontech) with the use of the polymerase chain reaction
(PCR) [35] and primers based on the sequence deposited in the Gen-
Bank database (GenBank U18300) [29]. Recognition sequences for
SmaI and HindIII were added to the 5P end of the forward primer
and the 3P end of the reverse primer, respectively, to facilitate plasmid
construction. The PCR product was cloned into the pGEM-T Easy
vector (Promega) to yield pGTddb2. The cDNA insert was sequenced
by the dideoxynucleotide method [36] with the use of a T7 or SP6
primer complementary to a vector region immediately adjacent to the
insert. The continuity of the open reading frame in pGTddb2 was also
con¢rmed by in vitro transcription and translation with the TNT
reticulocyte lysate system (Promega), as described [37].
2.3. Preparation of antibodies to DDB1 and to DDB2
For preparation of antibodies to DDB2, we digested pGTddb2 with
SmaI and HindIII, and inserted the released DNA fragment in frame
into pET15bDH, a modi¢ed version of pET15b (Invitrogen), to form
pETddb2. The recombinant protein produced from pETddb2 in bac-
teria was puri¢ed by chromatography on a nickel-NTA column (Qia-
gen). For preparation of antibodies to DDB1, a human DDB1 cDNA
spanning nucleotides 2386^3723 (EMBL database accession number
AJ002955) and encoding a 381-residue fragment of the protein was
isolated by PCR from human placenta. Recognition sequences for
SmaI and HindIII were added to the 5P end of the forward primer
and the 3P end of the reverse primer, respectively. The DDB1 cDNA
was inserted in frame into pET15bDH to yield pETddb1, which was
then introduced into bacteria. The recombinant protein was puri¢ed
as for DDB2. Antibodies to DDB1 and to DDB2 were generated in
New Zealand White rabbits as described [38].
2.4. Generation of DDB2 transgenic cell lines
To generate cell lines that produce DDB2 antisense RNA, we trans-
fected HeLa-CPR cells with pcDNA3ddb2as, a modi¢ed form of
pcDNA3 (Invitrogen) that contains the full-length human DDB2
cDNA in the antisense orientation, a neomycin resistance gene, and
a green £uorescent protein gene. The transfected cells were subjected
to selection with medium containing G418 (300 Wg/ml) for 2 weeks,
and those expressing green £uorescent protein were identi¢ed by £uo-
rescence microscopy [39].
2.5. Recombinant adenovirus and infection
Replication-de¢cient recombinant adenoviruses containing human
ddb2 were generated as previously described [40] according to the
method of He et al. [41]. Human ddb2 sequence that contains the
full length of the open reading frame was ampli¢ed by PCR according
to the reported sequence ([29], EMBL database accession number
U18300). A 1.3-kb NotI/HindIII wild-type ddb2 fragment from
pcDNA 3.1-ddb2 was ligated with pAdTrack-CMV. A ddb2 mutant
(XP82TO) [27] fragment was released by StuI and NotI and was also
ligated with pAdTrack-CMV. After restriction enzyme mapping, lin-
earized pAdTrack-CMV-ddb2 was cotransformed with pAdEasy1
into BJ5183 competent bacteria to generate recombinant pAdEasy1-
GFP- ddb2. Recombinant viruses were produced by transfecting lin-
earized pAdEasy1-GFP-ddb2 into 293 cells using lipofectamine re-
agent (Gibco). For large-scale virus production, the recombinant vi-
ruses were subjected to CsCl gradient centrifugation. The titer of viral
stocks was determined by spectrophotometer at 260 nm, and one
OD260 represents approximately 1012 pfu/ml.
Cells growing in log phase were infected with either empty or ddb2
adenovirus. After 30 h, cells were left untreated or treated with var-
ious doses of UV for 24 h. Cells were washed with phosphate-bu¡ered
saline and stained with DAPI to analyze the morphology and percent-
age of apoptotic cells. Samples were analyzed under a microscope.
There were 50^60% cells infected by the virus (multiplicity of infection
(MOI), 500) as shown by green £uorescence.
2.6. Preparation of cell extracts and immunoblot analysis
Cells were washed twice with phosphate-bu¡ered saline and lysed
by incubation on ice for 30 min in 1 ml of modi¢ed radioimmuno-
precipitation bu¡er (50 mM Tris^HCl pH 7.4, 1% Nonidet P-40,
0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM
phenylmethylsulfonyl £uoride, 1 mM Na3VO4, 1 mM NaF, and apro-
tinin, leupeptin, and pepstatin each at 1 Wg/ml). Insoluble material
was removed by centrifugation using an Eppendorf centrifuge at
12 000 rpm for 10 min at 4‡C, and the resulting supernatant was saved
as cell extract. Protein concentration was measured by Bradford assay
with the Bio-Rad dye reagent [42].
For immunoblot analysis, equivalent amounts of protein from each
sample were fractionated by SDS^PAGE, and the separated proteins
were transferred to a polyvinylidene di£uoride membrane and exposed
to antibodies. Immune complexes were detected with enhanced chem-
iluminescence reagents (Pierce).
2.7. Analysis of viability and apoptosis
Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) colorimetric assay [43]. In
brief, cells were transferred to 96-well plates in a volume of 100 Wl
and, after 12 h, exposed to UV at 37‡C. The number of surviving cells
was determined after 72 h by their ability to convert the tetrazolium
salt of MTT into a formazan product. For assessment of apoptosis,
cells growing in six-well plates were exposed to UV, incubated for 24
h at 37‡C, ¢xed with methanol, and incubated for 30 min in the dark
with DAPI (2 Wg/ml). Floating cells from each well were also ¢xed
and added back to the respective wells. Cells were then examined with
a £uorescence microscope at a wavelength of 420 nm, and those ex-
hibiting morphological features of apoptosis, including chromatin
condensation and nuclear fragmentation [44], were counted in six to
eight randomly selected ¢elds. Five hundred nuclei were examined for
each sample, and the percentage of cells with apoptotic nuclei was
determined in three independent experiments.
3. Results
3.1. Abundance of DDB2 in UV-resistant HeLa cells
UV-induced viability of sensitive HeLa, and its resistant cell
lines (R1, R2, and R3), originally selected with increasing
concentrations of cisplatin, was determined (Fig. 1A). Inter-
estingly, cisplatin-selected cells are cross-resistant to UV. UV-
induced apoptotic resistance in the resistant cell lines (R1, R2,
and R3) was also determined (Fig. 1B). We previously showed
that UV-resistant HeLa cells exhibited increased DDB activity
and enhanced DNA repair compared with the parental cells
[17,45]. Given the importance of DDB2 in DDB activity and
DNA repair, we investigated the role of this protein in deter-
mination of UV sensitivity or resistance. With the use of im-
munoblot analysis, we examined the abundance of DDB1 and
DDB2 in the crude extracts of these cells. Both DDB1 and
DDB2 levels were increased in resistant cells, with most abun-
dance in R3 cells (Fig. 1C).
3.2. E¡ect of DDB2 depletion on acquired UV resistance
Although both DDB1 and DDB2 are required for recogni-
tion of UV-induced DNA damage [46], mutation in DDB2 is
associated with a defect in recognition and repair of UV-in-
duced DNA damage [47]. DDB2 might be a determinant of
UV sensitivity. This possibility was investigated further by
stable transfection of R3 cells with a vector encoding DDB2
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antisense RNA. In typical resulting cell lines, R3ddb2as #6
and #18, the abundance of DDB2 was reduced (Fig. 2A). We
next examined the e¡ects of depletion of DDB2 on UV-in-
duced apoptosis in the UV-resistant cells. Exposure of both
sensitive and resistant HeLa cells to UV induced a dose-de-
pendent increase in the percentage of apoptotic cells in both
DDB2 knockdown cell lines (Fig. 2B). Depleting DDB2 by
antisense cDNA expression restored the sensitivity of
R3ddb2as #18 cells to apoptosis-inducing e¡ects of UV to
levels similar to those apparent for sensitive HeLa cells.
These observations were con¢rmed by immunoblot analysis
of the activation of caspase-3 and DFF, which is required for
fragmentation of chromosomal DNA during apoptosis. Acti-
vation of DFF is mediated by caspase-3 and caspase-7 in vitro
[48]. Exposure of sensitive HeLa cells to UV at a dose of 40
J/m2 induced a marked decrease in the abundance of the cas-
pase-3 and DFF precursors (Fig. 3); this e¡ect was dose-de-
pendent (data not shown) and is indicative of the proteolytic
cleavage of this protein to yield active caspase-3 and DFF.
Whereas the extent of UV-induced activation of DFF was
greatly reduced in R3 cells, depletion of DDB2 from these
cells (R3ddb2as #6 and #18) restored the UV sensitivity of
caspase-3 and DFF activation to a level similar to that of
control HeLa cells. The average levels of corresponding apo-
ptosis are also indicated. These results thus suggested that
Fig. 1. Overexpression of DDB2 and apoptotic resistance in UV-re-
sistant HeLa cell lines. A: Cell viability to UV treatment. HeLa
(H), UV-resistant HeLa (R1, R2, R3) cells were exposed to the indi-
cated doses of UV, and, after incubation for 72 h, cytotoxicity was
assessed by the MTT assay. B: Apoptotic resistance in UV-resistant
cells. Data are expressed as percentage survival relative to the sur-
vival of untreated cells, and are means þ S.D. of values from three
independent experiments. C: Overexpression of DDB2 in UV-resis-
tant cells. Cell extracts (50 Wg of protein) of HeLa (H) cells, UV-re-
sistant HeLa cells (R1, R2, and R3) were subjected to immunoblot
analysis with antibodies to DDB1, to DDB2, or to L-actin.
Fig. 2. E¡ect of DDB2 antisense cDNA expression on the abun-
dance of DDB2 and on UV-induced apoptosis in UV-resistant
HeLa cells. A: E¡ect of DDB2 antisense cDNA expression on the
abundance of DDB2. Cell extracts (50 Wg of protein) of UV-resis-
tant HeLa (R3) cells, and R3 cells stably transfected with DDB2
antisense cDNA (HRddb2as #6, #18 cells) were subjected to immu-
noblot analysis with antibodies to DDB1, to DDB2, or to L-actin.
B: E¡ect of DDB2 depletion on UV-induced apoptosis. The per-
centage of apoptotic cells was determined by DAPI staining 24 h
after exposure to the indicated doses of UV. Data are means þ S.D.
of values from three independent experiments.
Fig. 3. Depleting DDB2 sensitizes UV-induced activation of cas-
pase-3 and DFF. HeLa (H), UV-resistant HeLa (R3), and DDB2-
depleted R3 (R3ddb2as #6, #18) cells were exposed or not to UV
(40 J/m2) and, after 24 h, were lysed. Cell extracts (50 Wg of pro-
tein) were then subjected to immunoblot analysis with antibodies to
caspase-3, to DFF, or to L-actin. The percentage of apoptotic cells,
shown below, was determined by DAPI staining 24 h after exposure
to the indicated doses of UV. Data are means þ S.D. of values from
three independent experiments.
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DDB2 overexpression might protect against UV-induced apo-
ptosis.
3.3. E¡ects of DDB2 overexpression on UV-induced apoptosis
The potentiation of UV-induced apoptosis in R3 cells by
depleting DDB2 suggested that DDB2 modulates these phe-
nomena. To test this hypothesis further, we examined the
e¡ects of DDB2 overexpression in DDB2-depleted cells
(R3ddb2as #18, or R18), in which DDB2 is nearly undetect-
able. We introduced recombinant adenoviruses, which carry
the ddb2 gene, into these cells. Exposure of R18 cells to UV at
a dose of 80 J/m2 induced a marked decrease in the abun-
dance of the caspase-3 and DFF precursors (Fig. 4A), where-
as the extent of UV-induced activation of caspase-3 and DFF
was greatly reduced in DDB2-overexpressing cells (R18/
DDB2). Interestingly, overexpressing DDB2 mutant (R18/
DDB2M) also greatly reduced UV-induced activation of cas-
pases-3 and DFF. The extent of UV-induced apoptosis in
these cells was reduced relative to that apparent in R18 cells
(Fig. 4B).
4. Discussion
We have shown that the abundance of DDB2 is increased
in UV-resistant HeLa cell lines compared with that in the
parental cell line, and that depletion of DDB2 from resistant
cells by expression of DDB2 antisense cDNA restored their
sensitivities to UV-induced apoptosis to the original values.
Our results therefore suggest that overexpression of DDB2
may contribute to the acquired UV resistance of HeLa cells.
This conclusion was further supported by our observation
that overexpression of recombinant DDB2 in DDB2-depleted
cells protected these cells from UV-induced apoptosis. Deple-
tion of DDB2 from R3 cells did not a¡ect apoptosis induced
by cisplatin or mitomycin C (data not shown), suggesting that
modulation of apoptosis by DDB2 may be stimulus-speci¢c.
DFF, a heterodimeric protein composed of 45-kDa cata-
lytic (DFF45) and 40-kDa regulatory (DFF40) subunits, me-
diates fragmentation of nuclear DNA and chromatin conden-
sation in apoptotic cells [8,48]. The extent of UV-induced
activation of DFF in resistant R3 cells was reduced compared
with that apparent in UV-sensitive HeLa cells. DFF is acti-
vated by caspases-3 and -7 in vitro [49], and activation of
these caspases in the cytosol appears to be a critical step in
apoptosis in mammalian cells [6,50]. The extent of UV-in-
duced activation of caspase-3 in resistant cells was also re-
duced compared with that observed in UV-sensitive HeLa
cells. Depletion of DDB2 from resistant R3 cells restored
the extents of UV-induced activation of caspase-3 and DFF
to levels similar to those apparent in UV-sensitive HeLa cells.
Our results thus support the notion that various apoptotic
stimuli, including UV, activate caspase-3 and thereby induce
cleavage of apoptotic substrates such as DFF [6,48,51,52], and
that impaired activation of caspase-3 contributes to the devel-
opment of cellular resistance to UV in HeLa cells. These re-
sults also suggest that DDB2 may be a regulator for the acti-
vation of executioner caspases during UV-induced apoptosis.
Microinjection of puri¢ed DDB proteins into XP-E cells
corrects the defect in DNA repair [24,25], suggesting that
these proteins may play a speci¢c role in the repair of chro-
mosomal DNA. In the present study, depletion of DDB2
from UV-resistant HeLa cells, which exhibit enhanced DNA
repair [17,46], increased the sensitivity of the cells to UV-in-
duced apoptosis. Overexpression of DDB2 has also been
shown to potentiate global genomic repair in hamster cells
[47]. These observations further suggest that DDB2 functions
in the repair of UV-induced DNA damage, and that the intra-
cellular concentration of this protein is an important determi-
nant of acquired UV resistance. The importance of DDB2 in
the UV response is also supported by the observation that a
subset of XP-E cells that expressed DDB1 but in which the
DDB2 gene was mutated did not exhibit DDB activity [27].
Interestingly, overexpression of DDB2 mutant, which failed to
interact with DDB1 and to induce DDB activity, in DDB2-
depleted HeLa (R18) cells also inhibits UV-induced activation
of caspase-3 and DFF. These results suggest that regulation of
UV-induced apoptosis by DDB2 may be independent of DNA
repair. Although a recent study also showed that overexpres-
sion of DDB2 by stable transfection in hamster V79 cells
increased DDB activity [47], DDB2 overexpression did not
protect the cells from UV cytotoxicity as measured by a col-
ony formation assay. In contrast, we showed that overexpres-
sion of DDB2 protected HeLa cells from UV-induced apopto-
sis. Since apoptosis appears to be a major cell death pathway
after UV, this apparent discrepancy is likely due to the di¡er-
ence between the cell lines.
Fig. 4. Overexpressing DDB2 inhibits UV-induced activation of cas-
pase-3 and apoptosis in DDB2-depleted cells. A: Inhibition of acti-
vation of caspase-3 and apoptosis by overexpressing DDB2.
R3ddb2as #18 (R18) and R18/DDB2 or R18/DDB2M cells (which
overexpress human DDB2 or DDB2 mutant) were exposed to the
indicated doses of UV and then incubated for 24 h. Cell extracts
(50 Wg of protein) were subjected to immunoblot analysis with anti-
bodies to caspase-3, to DFF, or to L-actin. B: Inhibition of UV-in-
duced apoptosis by overexpressing DDB2. The percentage of apo-
ptotic cells was determined by DAPI staining 24 h after exposure to
the indicated doses of UV. Data are means þ S.D. of values from
three independent experiments.
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